<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Ms. Qiaosi Tang</submitter><funding>American Cancer Society (ACS)</funding><funding>HHS | NIH | National Cancer Institute (NCI)</funding><journal>EMBO Reports</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-SCDT-EMBOR-2019-48351V1P</full_dataset_link><abstract>Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer worldwide. The most commonly mutated gene in ESCC is TP53. Using a combinatorial genetic and carcinogenic approach, we generate a novel mouse model of ESCC expressing either mutant or null p53 and show that mutant p53 exhibits enhanced tumorigenic properties and displays a distinct genomic profile. Through RNA-seq analysis we identify several endocytic recycling genes, including Rab Coupling Protein (Rab11-FIP1), which are significantly downregulated in mutant p53 tumor cells. In 3-dimensional (3D) organoid models, genetic knockdown of Rab11-FIP1 results in increased organoid size. Loss of Rab11-FIP1 increases tumor cell invasion in part through mutant p53 but also in an independent manner.  Furthermore, loss of Rab11-FIP1 in human ESCC cell lines decreases E-cadherin expression and increases mesenchymal lineage specific markers, suggesting induction of epithelial-mesenchymal transition (EMT). Rab11-FIP1 regulates EMT through direct inhibition of Zeb1, a key EMT transcriptional factor. Our novel findings reveal that Rab11-FIP1 regulates organoid formation, tumor cell invasion and EMT.</abstract><repository>biostudies-other</repository><funding_grant_id>P01-CA098101</funding_grant_id><funding_grant_id>Research Professorship (AKR)</funding_grant_id><funding_grant_id>P30-CA01369645</funding_grant_id><pubmed_authors>Ms. Qiaosi Tang</pubmed_authors><pubmed_authors>E. Paul Wileyto</pubmed_authors><pubmed_authors>Adam Bass</pubmed_authors><pubmed_authors>Dr. Tatiana Karakasheva</pubmed_authors><pubmed_authors>Dr. Ashley, A. Lento</pubmed_authors><pubmed_authors>Dr. Kensuke Suzuki</pubmed_authors><pubmed_authors>Gizem Efe</pubmed_authors><pubmed_authors>Véronique Giroux</pubmed_authors><pubmed_authors>Dr. Hiroshi Nakagawa</pubmed_authors><pubmed_authors>Dr. Anil, K. Rustgi</pubmed_authors><pubmed_authors>Apple Long</pubmed_authors><pubmed_authors>Andres, J. Klein-Szanto</pubmed_authors><pubmed_authors>Mr. Mirazul Islam</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rab11-FIP1 mediates Epithelial-Mesenchymal Transition and invasion in esophageal cancer</name><description>Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer worldwide. The most commonly mutated gene in ESCC is TP53. Using a combinatorial genetic and carcinogenic approach, we generate a novel mouse model of ESCC expressing either mutant or null p53 and show that mutant p53 exhibits enhanced tumorigenic properties and displays a distinct genomic profile. Through RNA-seq analysis we identify several endocytic recycling genes, including Rab Coupling Protein (Rab11-FIP1), which are significantly downregulated in mutant p53 tumor cells. In 3-dimensional (3D) organoid models, genetic knockdown of Rab11-FIP1 results in increased organoid size. Loss of Rab11-FIP1 increases tumor cell invasion in part through mutant p53 but also in an independent manner.  Furthermore, loss of Rab11-FIP1 in human ESCC cell lines decreases E-cadherin expression and increases mesenchymal lineage specific markers, suggesting induction of epithelial-mesenchymal transition (EMT). Rab11-FIP1 regulates EMT through direct inhibition of Zeb1, a key EMT transcriptional factor. Our novel findings reveal that Rab11-FIP1 regulates organoid formation, tumor cell invasion and EMT.</description><dates><release>2021-02-15T00:00:00Z</release><modification>2021-02-15T21:00:22Z</modification><creation>2021-02-15T21:00:22Z</creation></dates><accession>S-SCDT-EMBOR-2019-48351V1P</accession><cross_references><doi>10.15252/embr.201948351</doi></cross_references></HashMap>